Management of Spasticity from Spinal Cord Dysfunction

Neurologic Clinics

Volumn 31, Issue 1, 2013, Pages 269-286

  Strommen, Jeffrey A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Benzodiazepines; Chemodenervation; Clonodine; Intrathecal baclofen; Spasticity; Tizanidine; Upper motor neuron syndrome

Indexed keywords

4 AMINOPYRIDINE; BACLOFEN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; CARISOPRODOL; CLONIDINE; CYCLOBENZAPRINE; DANTROLENE; DIAZEPAM; GABAPENTIN; NABILONE; PHENOL; PLACEBO; TIZANIDINE; UNCLASSIFIED DRUG; XANAFLEX;

ACHILLES TENDON; ACUTE ABDOMEN; ASHWORTH SCALE; ATTENTION; BEDTIME DOSAGE; CATHETER; CAUSALGIA; COGNITIVE DEFECT; COMPRESSION STOCKING; COORDINATION DISORDER; DECUBITUS; DEEP VEIN THROMBOSIS; DENERVATION; DISEASE SEVERITY; DIZZINESS; DROWSINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG INTOXICATION; DRUG METABOLISM; DRUG WITHDRAWAL; EDEMA; FRACTURE; FUNCTIONAL ELECTRICAL STIMULATION; HAMSTRING; HEADACHE; HEMODYNAMICS; HUMAN; LAMINECTOMY; LUMBAR PUNCTURE; MODIFIED ASHWORTH SCALE; MOTOR NERVE BLOCK; MULTIPLE SCLEROSIS; MUSCLE CONTRACTURE; MUSCLE HYPOTONIA; MUSCLE STRETCHING; NAUSEA AND VOMITING; NEUROLYSIS; NEUROMUSCULAR ELECTRICAL STIMULATION; NEUROPATHIC PAIN; NOCICEPTION; PARESTHESIA; PATIENT EDUCATION; PENN SPASM FREQUENCY SCALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; REVIEW; RHIZOTOMY; SEDATION; SIDE EFFECT; SKIN EXFOLIATION; SPASM FREQUENCY SCORE; SPASTICITY; SPINAL CORD DISEASE; SPINAL CORD INJURY; SPLINTING; TENDON SURGERY; TENDON TRANSFER; UROLITHIASIS; WEAKNESS;

HUMANS; MUSCLE SPASTICITY; PAIN; PAIN MANAGEMENT; PRESSURE ULCER; SPINAL CORD DISEASES;

EID: 84870222379     PISSN: 07338619     EISSN: 15579875     Source Type: Journal    
DOI: 10.1016/j.ncl.2012.09.013     Document Type: Review

References (49)

1. Lance J. Pathophysiology of spasticity and clinical experience with baclofen. Spasticity: disordered motor control 1980, 185-204. Yearbook, Chicago. J. Lance, R. Feldman, R. Young (Eds.).
2. Pandyan A.D., Gregoric M., Barnes M.P., et al. Spasticity: Clinical perceptions, neurological realities and meaningful measurement. Disabil Rehabil 2005, 27(1/2):2-6.
3. Kumru H., Murillo N., Samso J.V., et al. Reduction of spasticity with repetitive transcranial magnetic stimulation in patients with spinal cord injury. Neurorehabil Neural Repair 2010, 24(5):435-441.
4. Levi R., Hultling C., Seiger A. The Stockholm Spinal Cord Injury Study: 2. Association between clinical patient characteristics and post-acute medical problems. Paraplegia 1995, 33:585-594.
5. Elia E.A., Filippini G., Calandrella D., et al. Botulinum neurotoxins for post-stroke spasticity in adults: a systemic review. Mov Disord 2009, 24(6):801-812.
6. Maynard F.M., Karunas R.S., Waring W.P. Epidemiology of spasticity following traumatic spinal cord injury. Arch Phys Med Rehabil 1990, 71(8):566-569.
7. Rizzo M.A., Hadjimichael O.C., Preiningerova J., et al. Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult Scler 2004, 10(5):589-595.
8. Elbasiouny S.M., Moroz D., Bakr M.M., et al. Management of spasticity after spinal cord injury: current techniques and future directions. Neurorehabil Neural Repair 2010, 24(1):23-33.
9. Rushworth G. Spasticity and rigidity: an experimental study and review. J Neurol Neurosurg Psychiatry 1960, 23:99-118.
10. Bohannon R., Smith M. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987, 67(2):206.
11. Ashworth B. Preliminary trial of carisoprodal in multiple sclerosis. Practitioner 1964, 192:540-542.
12. Beiring-Sorensen F., Neilsen J.B., Klinge K. Spasticity-assessment; a review. Spinal Cord 2006, 44:708-722.
13. Linsenmeyer T.A. Acute management of Autonomic Dysreflexia: Individual with spinal cord injury presenting to health-care facilities. Clinical practice guidelines 2001, Consortium for Spinal Cord Medicine. Paralyzed Veterans Association. 2nd edition.
14. Merritt J.L. Management of spasticity in spinal cord injury. Mayo Clin Proc 1981, 56(10):614-622.
15. Schmit B.D., Dewald J.P.A., Rymer W.Z. Stretch reflex adaptation in elbow flexors during repeated passive movements in unilateral brain-injured patients. Arch Phys Med Rehabil 2000, 81:269-278.
16. Bohannon R.W. Tilt table standing for reducing spasticity after spinal cord injury. Arch Phys Med Rehabil 1993, 74(10):1121-1122.
17. Kunkel C.F., Scremin A.M., Eisenberg B., et al. Effect of "standing" on spasticity, contracture, and osteoporosis in paralyzed males. Arch Phys Med Rehabil 1993, 74:73-78.
18. Shields R.K., Dudley-Javoroski S. Monitoring standing wheelchair use after spinal cord injury: a case report. Disabil Rehabil 2005, 27:142-146.
19. Abramson A.S. Exercise in paraplegia. Therapeuptic exercise. 3d edition 1985, WiHas s end Wilkins, Baltimore (MD). J.V. Basmajian (Ed.).
20. Elovic E.P., Eisenberg M.E., Jasey N.N. Spasticity and muscle overactivity as components of the upper motor neuron syndrome. Delisa's physical medicine and rehabilitation. Principles and practice 2010, 1319-1344. Lippincott Williams and Wilkins, Philidelphia. 5th edition. W. Frontera (Ed.).
21. Brouwer B., Davidson L.K., Olney S. Serial casting in idiopathic toe-walkers and children with spastic cerebral palsy. J Pediatr Orthop 2000, 20(2):221-225.
22. Krause P., Szecsi J., Straube A. Changes in spastic muscle tone increase in patient with spinal cord injury using functional electrical stimulation and passive leg movements. Clin Rehabil 2008, 22(7):627-634.
23. Murillo N., Kumru H., Vidal-Samso J., et al. Decrease of spasticity with muscle vibration in patients with spinal cord injury. Clin Neurophysiol 2011, 122:1183-1189.
24. Van der Salm A., Veltink P.H., ljzerman M.J., et al. Comparison of electric stimulation methods for reduction of triceps surae spasticity in spinal cord injury. Arch Phys Med Rehabil 2006, 87(2):222-228.
25. Granat M.H., Ferguson A.C., Andrews B.J., et al. The role of functional electrical stimulation in the rehabilitation of patients with incomplete spinal cord injury-observed benefits during gait studies. Paraplegia 1993, 31(4):207-215.
26. Robinson C.J., Kett N.A., Bolam J.M. Spasticity in spinal cord injured patients: 1. Short-term effects of surface electrical stimulation. Arch Phys Med Rehabil 1988, 69(8):598-604.
27. Gracies J.M., Nance P., Elovic E., et al. Traditional pharmacological treatments for spasticity. Part II: General and regional treatments. Muscle Nerve Suppl 1997, 6:S92-120.
28. CPS Compendium of pharmaceuticals and specialties 1998, 883-884. Canadian Pharmacists Association, Ottawa (Ontario). 33rd edition. M.C. Gillis (Ed.).
29. Aydin G., Tomruk S., Keles I., et al. Transcutaneous electrical stimulation versus baclofen in spasticity: clinical and electrophysiologic comparison. Am J Phys Med Rehabil 2005, 84(8):584-592.
30. Tseng T.C., Wang S.C. Locus of action of centrally acting muscle relaxants, diazepam and tybamate. J Pharmacol Exp Ther 1971, 178(2):350-360.
31. Bass B., Weinshenker B., Rice G.P., et al. Tizanidine versus baclofen in the treatment of spasticity in patients with multiple sclerosis. Can J Neurol Sci 1988, 15(1):15-19.
32. Eyssette M., Rohmer F., Serratrice G., et al. Multi-center, double-blind trial of a novel antispastic agent, tizanidine, in spasticity associated with multiple sclerosis. Curr Med Res Opin 1988, 10(10):699-708.
33. Nance P.W., Bugaresti J., Shellenberger K., et al. Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. North American Tizanidine Study Group. Neurology 1994, 44:S44-S51.
34. Nance P.W., Shears A.H., Nance D.M. Clonidine in spinal cord injury. Can Med Assoc J 1985, 133:41-42.
35. Yablon S.A., Sipski M.L. Effect of transdermal clonidine on spinal spasticy. Am J Phys Med Rehabil 1993, 72:154-157.
36. Ward A., Chaffman M.O., Sorkin E.M. Dantrolene: a review of it's pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of it's use in muscle spasticity. Drugs 1986, 32:130-168.
37. Gruenthal M., Mueller M., Olson W.L., et al. Gabapentin for the treatment of spasticity in patients with spinal cord injury. Spinal Cord 1997, 35(10):686-689.
38. Collin C., Davies P., Mutiboko I.K., et al. Randomized controlled trial of cannabis-bases medicine in spasticity caused by multiple sclerosis. Eur J Neurol 2007, 14(3):290-296.
39. Pooyania S., Ethans K., Szturm T., et al. A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury. Arch Phys Med Rehabil 2010, 91(5):703-707.
40. Hayes K.C. Fampridine-SR for multiple sclerosis and spinal cord injury. Expert Rev Neurother 2007, 7(5):453-461.
41. Wenzel R., Jones D., Borrego J.A. Comparing two botulinum toxin type A formulations using manufacturers' product summaries. J Clin Pharm Ther 2007, 32(4):387-402.
42. Dralle D., Muller H., Zierski J., et al. Intrathecal baclofen for spasticity. Lancet 1985, 2(8462):1103.
43. Coffey R.J., Edgar T.S., Francisco G.E., et al. Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life threatening syndrome. Arch Phys Med Rehabil 2002, 83:735-741.
44. Penn R.D., Savoy S.M., Corcos D., et al. Intrathecal baclofen for severe spinal spasticity. N Engl J Med 1989, 320:1517-1521.
45. Coffey J.R., Cahill D., Steers W., et al. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg 1993, 78:226-232.
46. Nance P.W., Schreyvers O., Schmidt B., et al. Intrathecal baclofen therapy for adults with spinal spasticity: therapeutic efficacy and effect on hospital admissions. Can J Neurol Sci 1995, 22:22-29.
47. Azouvi P., Mane M., Thiebaut J.B., et al. Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow-up. Arch Phys Med Rehabil 1996, 77:35-39.
48. Broseta J., Garcia-March G., Sanchez-Ledesma M.J., et al. Chronic intrathecal administration in severe spasticity. Stereotact Funct Neurosurg 1990, 54-55:147-153.
49. Falci S.P., Indeck C., Lammertse D.P. Posttraumatic spinal cord tethering and syringomyelia; surgical treatment and long-term outcome. J Neurosurg Spine 2009, 11:445-460.